Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
A Study of JNJ-67835989 in Healthy Participants (NCT04844411)Janssen Research & Development, LLC2021-04-27
Pharmacokinetics, Tolerability and Safety of NEX-18a (NCT05048498)Nanexa AB2021-04-27
An Open-label, Exploratory Study to Investigate the Efficacy of BDNF Essentials® on Cognition (NCT04860778)Researched Nutritionals LLC2021-04-27
A Study to Evaluate How Well Single and Multiple Doses of GLPG3121-modified Release Formulation Are Tolerated in Healthy, Adult Subjects (NCT04856358)Lakefront Biotherapeutics NV2021-04-27
Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma (NCT04756726)C4 Therapeutics, Inc.2021-04-27
A Study of GFH312 in Healthy Subjects (NCT04676711)GenFleet Therapeutics (Australia) Pty Ltd.2021-04-27
Glutamine PET Imaging Colorectal Cancer (NCT03275974)M.D. Anderson Cancer Center2021-04-27
Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell Cancers (NCT04804254)AbbVie2021-04-27
A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA) (NCT04913519)Technoderma Medicines Inc.2021-04-27
Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer (NCT04868045)Memorial Sloan Kettering Cancer Center2021-04-27
Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine (NCT04854746)Vaxart2021-04-26
Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST) (NCT04590118)Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.2021-04-26
Pharmacokinetic Study Comparing Tiotropium Easyhaler® and Spiriva® HandiHaler® (NCT04850144)Orion Corporation, Orion Pharma2021-04-26
JAB-3068 Activity in Adult Patients With Advanced Solid Tumors (NCT04721223)Jacobio Pharmaceuticals Co., Ltd.2021-04-26
Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymphoma (NCT04818372)Keymed Biosciences Co.Ltd2021-04-26
A Study of ABTL0812 in Pancreatic Cancer (NCT03417921)Ability Pharmaceuticals SL2021-04-26
A Study of LY3484356 in Healthy Female Participants (NCT04840888)Eli Lilly and Company2021-04-26
Single Ascending and Multiple Dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male and Female Adult Subjects (NCT05077865)TNF Pharmaceuticals, Inc.2021-04-26
Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies (NCT04732845)Benjamin Tomlinson2021-04-26
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peritoneal Metastasis (NCT04913662)Seoul National University Bundang Hospital2021-04-26
NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer (NCT04659629)Neurogene Inc.2021-04-26
A Study to Determine the Absolute Oral Bioavailability of Quizartinib Using a Radiolabeled Microtracer in Healthy Subjects (NCT04796831)Daiichi Sankyo2021-04-26
Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults (NCT04866069)Osman ERGANIS, PhD, Prof2021-04-25
A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19 (NCT04869592)National Vaccine and Serum Institute, China2021-04-25
Bronchopulmonary PK of AT-527 (R07496998) (NCT04877769)Atea Pharmaceuticals, Inc.2021-04-25
68Ga-NOTA Evans Blue PET/CT in Patients With Lymphatic System Related Diseases (NCT05140083)First Affiliated Hospital of Fujian Medical University2021-04-25
Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor (NCT05278364)Shouyao Holdings (Beijing) Co. LTD2021-04-23
Safety and Efficacy Study of Matrilin-3 Pretreated Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration (NCT05011474)Inbo Han2021-04-23
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignant Tumors (NCT04805060)Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2021-04-23
A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer (NCT04818333)Jiangsu HengRui Medicine Co., Ltd.2021-04-23
TGRX-326 Chinese Phase I for Advanced Non-small Cell Lung Cancer (NSCLC) (NCT05441956)Shenzhen TargetRx Co., Ltd.2021-04-23
Azacytidine, Bendamustine, Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's Lymphoma (NCT04897477)Chinese PLA General Hospital2021-04-22
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Rozanolixizumab Administered Subcutaneously Via Manual Push Versus Syringe Driver to Healthy Participants (NCT04828343)UCB Biopharma SRL2021-04-22
Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid Tumors (NCT05865925)Luye Pharma Group Ltd.2021-04-22
Liver Transplantation With Tregs at UCSF (NCT03654040)National Institute of Allergy and Infectious Diseases (NIAID)2021-04-22
T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer (NCT04611126)Inge Marie Svane2021-04-22
Vaginal Microbiota Transplant (NCT04046900)Douglas Kwon2021-04-22
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve (NCT04752722)enGene, Inc.2021-04-22
Pharmacokinetics of Sotorasib in Healthy Participants and Participants With Moderate or Severe Hepatic Impairment (NCT04887064)Amgen2021-04-22
Drug-drug Interaction Study of Midazolam and AT-527 (R07496998) (NCT04865445)Atea Pharmaceuticals, Inc.2021-04-22
L-Citrulline Dose Finding Safety Study in MELAS (NCT03952234)Baylor College of Medicine2021-04-22
IMPase in Treatment-resistant Depression (NCT05117710)University of Oxford2021-04-22
Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation (NCT04840992)CanSino Biologics Inc.2021-04-21
Mogamulizumab and Extracorporeal Photopheresis for the Treatment of Sezary Syndrome or Mycosis Fungoides (NCT04676087)Emory University2021-04-21
Study 102: Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase) (NCT04829435)Allena Pharmaceuticals2021-04-21
A Relative Bioavailability and Food-Effect Study of the Fixed Dose Combination of GSK3640254 and Dolutegravir (DTG) in Healthy Participants (NCT04857892)ViiV Healthcare2021-04-21
A Clinical Study of MIL93 in Solid Tumors. (NCT04671875)Beijing Mabworks Biotech Co., Ltd.2021-04-21
A Phase I Open-label Study for Subjects With Advanced Malignancies (NCT04136834)Athenex, Inc.2021-04-21
A Study to Investigate the Effect of Food on the PK, PD of CKD-381 in Healthy Volunteers (NCT04830930)Chong Kun Dang Pharmaceutical2021-04-21
TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors (NCT06088472)Grit Biotechnology2021-04-21
Glumetinib Combined With Toripalimab in the Treatment of Relapsed or Metastatic Non-small Cell Lung Cancer. (NCT04797702)Shanghai Junshi Bioscience Co., Ltd.2021-04-21
Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide (NCT04997317)University Hospital, Basel, Switzerland2021-04-21
Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19 (NCT04674566)Corat Therapeutics Gmbh2021-04-21
Assessing the Safety, Tolerability and Pharmacokinetics(PK) of DZD9008 and the Effect of Low-fat Meal on PK of DZD9008 in Healthy Adult Participants (NCT04909242)Dizal Pharmaceuticals2021-04-21
The Recombinant Humanized Anti-TIGIT Monoclonal Antibody (JS006) Monotherapy and in Combination With Toripalimab in Patients With Advanced Tumor (NCT05061628)Shanghai Junshi Bioscience Co., Ltd.2021-04-21
Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma (NCT03743298)Aivita Biomedical, Inc.2021-04-21
A Study of LY3484356 in Women With Breast Cancer Before Having Surgery (NCT04647487)Eli Lilly and Company2021-04-21
INO 5401 Vaccination in BRCA1/2 Mutation Carriers (NCT04367675)Abramson Cancer Center at Penn Medicine2021-04-20
A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes (NCT04698018)Novo Nordisk A/S2021-04-20
M1 Schizophrenia PET Study (NCT05105542)Yale University2021-04-20
Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis (NCT04806581)RenJi Hospital2021-04-20
Evaluate Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI7352 in Healthy Volunteers (NCT04770428)AstraZeneca2021-04-20
A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM) (NCT04776018)Takeda2021-04-20
ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults (NCT04856865)Alladapt Immunotherapeutics, Inc.2021-04-20
A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function (NCT04398680)GlaxoSmithKline2021-04-20
A Study to Find a Safe and Effective Dose of BI 1701963 Alone and in Combination With BI 3011441 in Patients With Advanced Cancer and a Certain Mutation (Kirsten Rat Sarcoma Viral Oncogene Homologue [KRAS]) (NCT04835714)Boehringer Ingelheim2021-04-20
Effect of IMMUNEPOTENT-CRP on Serum Pro-Inflammatory Cytokines in Mild to Moderate COVID-19 (NCT06676709)Universidad Autonoma de Nuevo Leon2021-04-20
Safety, Tolerability and Pharmacokinetics of Eptinezumab in Healthy Chinese Subjects (NCT05045781)H. Lundbeck A/S2021-04-20
Therapeutic Hepatitis C Virus Vaccine (NCT04318379)GeneCure Biotechnologies2021-04-20
Acupuncture for the Treatment of Medication-Dependent Hypotension in Heart Failure (NCT04952935)Scripps Health2021-04-20
RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer (NCT04338763)Rise Biopharmaceuticals, Inc.2021-04-19
Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy (NCT04758533)Hospital Infantil Universitario Niño Jesús, Madrid, Spain2021-04-19
KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial (NCT04844619)Sun Yat-sen University2021-04-19
Safety, Tolerability and PK of a Single Subcutaneous Injection of XmAb27564 in Healthy Volunteers (NCT04857866)Xencor, Inc.2021-04-19
Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma. (NCT04258072)Samsung Medical Center2021-04-19
Personalized Cancer Vaccine in Egyptian Cancer Patients (NCT05059821)zeinab ahmed yousif hasan ashour2021-04-19
Trichomylin® Safety, Tolerability & Pharmacokinetics in Healthy Adults and First in Human Osteoarthritis Pain Evaluation (NCT04867057)ZYUS Life Sciences Inc.2021-04-19
Mass Balance Study of TS-142 in Healthy Adult Subjects. (NCT04814771)Taisho Pharmaceutical Co., Ltd.2021-04-19
TAC T-cells for the Treatment of HER2-positive Solid Tumors (NCT04727151)Triumvira Immunologics, Inc.2021-04-19
Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells (NCT04813653)Tel-Aviv Sourasky Medical Center2021-04-18
Effect of Cyclosporine on the Pharmacokinetics (PK) of AT-527 (R07496998) (NCT04849299)Atea Pharmaceuticals, Inc.2021-04-18
Menstrual Blood Stem Cells in Severe Covid-19 (NCT05019287)Avicenna Research Institute2021-04-17
Effect of Fluconazole on the Pharmacokinetics of Pyrotinib in Healthy Subjects (NCT04850651)Jiangsu HengRui Medicine Co., Ltd.2021-04-16
A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML (NCT04730258)Treadwell Therapeutics, Inc2021-04-16
RJV001 Study in Adults Receiving Abdominoplasty (NCT04821648)Rejuven Dermaceutical Co., Ltd.2021-04-16
A Clinical Study in Health Subjects to Evaluate 9MW1411 Injection (NCT04784312)Mabwell (Shanghai) Bioscience Co., Ltd.2021-04-16
Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease (NCT04806737)Oslo University Hospital2021-04-16
Bioequivalence Study for Crizotinib Encapsulated Microsphere Formulation (eMS) (NCT04856293)Pfizer2021-04-16
Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body of Adult Participants With Human Immuno-Deficiency Virus (HIV-1) (NCT04554966)AbbVie2021-04-16
Study to Evaluate Safety and Tolerability of a Single Dose of PF-06741086 in Chinese Adult Participants With Severe Hemophilia (NCT04878731)Pfizer2021-04-16
A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383. (NCT04810676)Chong Kun Dang Pharmaceutical2021-04-16
Safety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERS (NCT04119440)Universitätsklinikum Hamburg-Eppendorf2021-04-16
A Study to Compare the Pharmacokinetics and Safety Between BR9004 and BR9004-1 in Healthy Male Volunteers (NCT04889651)Boryung Pharmaceutical Co., Ltd2021-04-15
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer (NCT03709550)Roswell Park Cancer Institute2021-04-15
Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD (NCT04565171)Sunshine Lake Pharma Co., Ltd.2021-04-15
Effects of Delta9-tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R33 Study (NCT04080427)Wayne State University2021-04-15
Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies Malignancies (NCT04823091)Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2021-04-15
Assessing Health Electronically for Adolescent and Young Adult Oncology (NCT04484194)Seattle Children's Hospital2021-04-15
Bioequivalence Study of Apixaban 5 mg Film-Coated Tablet (NCT06817811)Dexa Medica Group2021-04-15
Senicapoc and Dehydrated Stomatocytosis (NCT04372498)Boston Children's Hospital2021-04-15
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.